These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 18402397)
1. [Pompe's disease: the role for early diagnosis and treatment]. Cerini E; Bini M; Donati A; Andaloro L; Compagnoni G Pediatr Med Chir; 2007; 29(5):270-2. PubMed ID: 18402397 [TBL] [Abstract][Full Text] [Related]
2. [Enzyme replacement therapy in Pompe's disease]. Merk T; Wibmer T; Schumann C; Krüger S Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875 [TBL] [Abstract][Full Text] [Related]
3. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987 [TBL] [Abstract][Full Text] [Related]
4. Monitoring cardiac function by B-type natriuretic peptide (BNP) in patients with infantile Pompe's disease treated with recombinant alpha-glucosidase. Hahn A; Schmidt D; Hagel KJ; Neubauer BA; Katz N Clin Lab; 2006; 52(11-12):615-9. PubMed ID: 17175893 [TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888 [TBL] [Abstract][Full Text] [Related]
6. Elimination of antibodies to recombinant enzyme in Pompe's disease. Mendelsohn NJ; Messinger YH; Rosenberg AS; Kishnani PS N Engl J Med; 2009 Jan; 360(2):194-5. PubMed ID: 19129538 [No Abstract] [Full Text] [Related]
14. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Ing RJ; Cook DR; Bengur RA; Williams EA; Eck J; Dear Gde L; Ross AK; Kern FH; Kishnani PS Paediatr Anaesth; 2004 Jun; 14(6):514-9. PubMed ID: 15153218 [TBL] [Abstract][Full Text] [Related]
15. A randomized study of alglucosidase alfa in late-onset Pompe's disease. van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176 [TBL] [Abstract][Full Text] [Related]
16. [Pompe's disease. Part II. Treatment strategies and enzyme replacement]. Illés Z; Várdi Visy K Ideggyogy Sz; 2009 Sep; 62(9-10):299-307. PubMed ID: 19835271 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Klinge L; Straub V; Neudorf U; Schaper J; Bosbach T; Görlinger K; Wallot M; Richards S; Voit T Neuromuscul Disord; 2005 Jan; 15(1):24-31. PubMed ID: 15639117 [TBL] [Abstract][Full Text] [Related]
18. Regional anesthetic techniques are an alternative to general anesthesia for infants with Pompe's disease. Walker RW; Briggs G; Bruce J; Fletcher J; Wraith ED Paediatr Anaesth; 2007 Jul; 17(7):697-702. PubMed ID: 17564654 [TBL] [Abstract][Full Text] [Related]
19. Angiocardiographic and enzyme studies in a patient with type II glycogenosis (Pompe's disease). A case report. Bonnici F; Shapiro R; Joffe HS; Petersen EM S Afr Med J; 1980 Nov; 58(21):860-2. PubMed ID: 6777881 [TBL] [Abstract][Full Text] [Related]
20. [A case report of anesthesia for a child with Pompe's disease (glycogen storage disease type II)]. Sakakibara M; Teramoto Y; Aoyama T; Takahashi T; Hara M; Maseki M; Yamaguchi S; Nakata J Masui; 2009 Feb; 58(2):219-22. PubMed ID: 19227183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]